🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06956365
Recruiting Not applicable

To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.

NCT06956365 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-05-14
Last updated
2025-05-04

Condition(s) studied

Cesarean Section

Investigational drug(s) / intervention(s)

Group-CGroup-O

Group-C: 100 iu carbetosin administered to carbetocin group

Group-O: In cesarean surgery, 5 IU of oxytocin will be administered after the baby delivered.

Study summary

To compare the effects of oxytocin and carbetocin, used as uterotonics in elective caesarean section surgeries, in terms of intraoperative hemodynamic changes.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients scheduled for caesarean sections * Between 18-40 years * ASA I-II group * Those who will undergo general anesthesia * Those between 35-40 weeks of pregnancy * 1st and 2nd caesarean sections Exclusion Criteria: * Those who prefer spinal or epidural anesthesia * Those who are outside the age range of 18-40 * Those who are ASA III and above * Those with HT, DM, cardiac and respiratory diseases * Preeclampsia, eclampsia, HELLP * Those with a history of drug use that affects the cardiovascular system * Placenta Previa, Placenta Acreta, Placenta Acreta

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Van Yuzuncu Yil University Van Tuşba Recruiting

More Yuzuncu Yil University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06956365 on ClinicalTrials.gov ↗ ← All trials in Turkey